KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Notes Payables (2016 - 2025)

Historic Notes Payables for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $1.3 million.

  • Bio-Rad Laboratories' Notes Payables rose 833.33% to $1.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 million, marking a year-over-year increase of 833.33%. This contributed to the annual value of $1.3 million for FY2025, which is 833.33% up from last year.
  • Latest data reveals that Bio-Rad Laboratories reported Notes Payables of $1.3 million as of Q4 2025, which was up 833.33% from $1.3 million recorded in Q3 2025.
  • Bio-Rad Laboratories' Notes Payables' 5-year high stood at $1.7 million during Q3 2021, with a 5-year trough of $448000.0 in Q3 2022.
  • Over the past 5 years, Bio-Rad Laboratories' median Notes Payables value was $511500.0 (recorded in 2022), while the average stood at $904400.0.
  • Its Notes Payables has fluctuated over the past 5 years, first crashed by 9959.3% in 2021, then soared by 16915.11% in 2025.
  • Bio-Rad Laboratories' Notes Payables (Quarter) stood at $489000.0 in 2021, then dropped by 4.91% to $465000.0 in 2022, then grew by 7.53% to $500000.0 in 2023, then surged by 140.0% to $1.2 million in 2024, then increased by 8.33% to $1.3 million in 2025.
  • Its Notes Payables was $1.3 million in Q4 2025, compared to $1.3 million in Q3 2025 and $1.3 million in Q2 2025.